Horizon Discovery CEO Darrin Disley wins Executive of the Year award at the SCRIP Awards 2014

08-Dec-2014 - United Kingdom

Dr Darrin Disley, the Chief Executive Officer of Horizon Discovery Group plc has been awarded Executive of the Year at last night’s Scrip Awards 2014 in London.

The Executive of the Year Award acknowledges excellence in the leadership of large and small pharmaceutical and biotechnology companies.  Dr. Disley has spearheaded the transformation of Horizon from start-up to one of the world’s leaders in the creation of tools for personalized medicine. From the Company’s launch in 2007 through 2013 he raised over £20 million in funding and defined the business model of building a company committed to accelerating the discovery of targeted personalized medicines, enabling the delivery of the right drugs to the right patient. Under his leadership, Horizon has gone from strength to strength, generating revenue growth on a compound basis of 126% in the six years to 2013. Further, he oversaw the listing of Horizon on the London Stock Exchange’s AIM market, generating £69 million in funding, nearly three times the original fund-raising goal, supporting the Company through its next phase of growth. Since the IPO he has overseen two M&A transactions including the combination screening services business CombinatoRx based in Cambridge, Massachusetts and the world-leading in vivo gene-editing business SAGE Labs based in St Louis, Missouri and Boyertown, Pennsylvania.

Since the float, Darrin has continued to drive the business with targeted acquisitions into fast-growing areas of the personalized medicines space and by expanding the suite of products and services available to customers, bolstering Horizon’s intellectual property through licensing agreements, and delivering high-value contracts with world-leading life sciences companies.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances